Emily Ruiz, MD, MPH, FAAD, a Mohs surgeon at Brigham and Women's Hospital and cutaneous oncologist at Dana-Farber Cancer Institute, discusses her recent Future Oncology article, "Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile."
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Dr. Battle on Skin of Color Update and Minimizing, Treating Complications from Energy-Based Devices
Eliot Battle, MD
Corey L. Hartman, MD
Sheryl Hoyer, MD
Christine Pak, MD
Isabella Zorra
Victoria Palmer, MBBS, MSC
